BE698102A - - Google Patents

Info

Publication number
BE698102A
BE698102A BE698102DA BE698102A BE 698102 A BE698102 A BE 698102A BE 698102D A BE698102D A BE 698102DA BE 698102 A BE698102 A BE 698102A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE698102A publication Critical patent/BE698102A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electric Connection Of Electric Components To Printed Circuits (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE698102D 1966-05-09 1967-05-08 BE698102A (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH671666 1966-05-09

Publications (1)

Publication Number Publication Date
BE698102A true BE698102A (cg-RX-API-DMAC7.html) 1967-11-08

Family

ID=74187416

Family Applications (1)

Application Number Title Priority Date Filing Date
BE698102D BE698102A (cg-RX-API-DMAC7.html) 1966-05-09 1967-05-08

Country Status (16)

Country Link
US (1) US3551564A (cg-RX-API-DMAC7.html)
JP (1) JPS5017524B1 (cg-RX-API-DMAC7.html)
BE (1) BE698102A (cg-RX-API-DMAC7.html)
CH (1) CH544053A (cg-RX-API-DMAC7.html)
DE (1) DE1617521C3 (cg-RX-API-DMAC7.html)
DK (1) DK117520B (cg-RX-API-DMAC7.html)
ES (1) ES340262A1 (cg-RX-API-DMAC7.html)
FI (1) FI48975C (cg-RX-API-DMAC7.html)
FR (1) FR1523606A (cg-RX-API-DMAC7.html)
GB (1) GB1176395A (cg-RX-API-DMAC7.html)
GR (1) GR35814B (cg-RX-API-DMAC7.html)
IL (1) IL27876A (cg-RX-API-DMAC7.html)
IT (1) IT1143624B (cg-RX-API-DMAC7.html)
NL (1) NL140736B (cg-RX-API-DMAC7.html)
NO (1) NO127486B (cg-RX-API-DMAC7.html)
SE (1) SE348112B (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2311214A1 (de) * 1972-03-16 1973-09-27 Hoffmann La Roche Wirkstoffkombination
FR2361103A1 (fr) * 1976-07-15 1978-03-10 Basf Ag Solutions de sulfonamide-trimethoprime

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZM3271A1 (en) * 1970-03-13 1972-10-23 Wellcome Found Improvements in or relating to injectable therapeutic compositions
US3728452A (en) * 1971-01-20 1973-04-17 Abic Ltd Water-soluble composition comprising sulfadimidine and pyrimethamine
DE2342213C3 (de) * 1972-10-12 1979-10-18 F. Hoffmann-La Roche & Co Ag, Basel (Schweiz) Verwendung von potenzierten SuIf onamiden bei der Behandlung oder Verhinderung von Fischinfektionen
US3985876A (en) * 1973-01-05 1976-10-12 Burroughs Wellcome Co. Chemotherapeutic solutions containing a sulphur and a salt of a 2,4-diamino-5-benzylpyrimidine
GB1485383A (en) * 1973-09-24 1977-09-08 Wellcome Found Injectable non-aqueous therapeutic compositions
GB1485382A (en) * 1973-09-24 1977-09-08 Wellcome Found Injectable therapeutic compositions
US4039543A (en) * 1974-12-24 1977-08-02 Hoffmann-La Roche Inc. Benzylpyrimidines
DK136934B (da) * 1976-02-06 1977-12-19 Rosco As Fremgangsmåde til fremstilling af en klar, stabil, injicerbar opløsning indeholdende et sulfonamid og en potentiator.
DE2731013C2 (de) * 1977-07-08 1982-07-15 Lentia Gmbh Verfahren zur Herstellung einer wäßrigen Infusionslösung
JPS54154775A (en) * 1978-05-24 1979-12-06 Wellcome Found Benzylpyrimidine derivative
DE2963408D1 (en) 1978-08-01 1982-09-16 Ciba Geigy Ag Stable medicinal solution on the basis of 2,6-diamino-5-(3',4',5'-trimethoxybenzyl)-pyrimidine(trimethoprim) and a sulphonamide, process for preparing and using it
US4303643A (en) * 1979-07-05 1981-12-01 Pfizer Inc. Sulfonamide compositions
HU180740B (en) * 1979-11-27 1983-04-29 Egyt Gyogyszervegyeszeti Gyar Process for producing sulfonamide-containing,injectable pharmaceutical composition of prolongated activity
AR220263A1 (es) * 1980-02-19 1980-10-15 Bago Lab Sa Procedimiento para obtener una preparacion inyectable de sulfonamida potenciada de baja irritabilidad
CH647412A5 (de) * 1980-03-25 1985-01-31 Hoffmann La Roche Pharmazeutische praeparate.
US4374826A (en) * 1980-07-21 1983-02-22 Pfizer Inc. Sulfonamide compositions
EP4417701A4 (en) * 2021-10-12 2025-03-05 Daan Gene Co., Ltd. IN VITRO PRESERVATIVES FOR DIAGNOSTIC REAGENTS AND USE THEREOF

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2311214A1 (de) * 1972-03-16 1973-09-27 Hoffmann La Roche Wirkstoffkombination
FR2181821A1 (cg-RX-API-DMAC7.html) * 1972-03-16 1973-12-07 Hoffmann La Roche
FR2361103A1 (fr) * 1976-07-15 1978-03-10 Basf Ag Solutions de sulfonamide-trimethoprime

Also Published As

Publication number Publication date
SE348112B (cg-RX-API-DMAC7.html) 1972-08-28
FI48975C (fi) 1975-03-10
DE1617521C3 (de) 1979-09-06
DE1617521B2 (de) 1979-01-04
ES340262A1 (es) 1968-06-01
CH544053A (de) 1973-11-15
IT1143624B (it) 1986-10-22
GB1176395A (en) 1970-01-01
DE1617521A1 (de) 1972-02-10
JPS5017524B1 (cg-RX-API-DMAC7.html) 1975-06-21
IL27876A (en) 1971-10-20
FR1523606A (fr) 1968-05-03
US3551564A (en) 1970-12-29
NL6706474A (cg-RX-API-DMAC7.html) 1967-11-10
DK117520B (da) 1970-05-04
NL140736B (nl) 1974-01-15
GR35814B (el) 1968-11-04
FI48975B (cg-RX-API-DMAC7.html) 1974-12-02
NO127486B (cg-RX-API-DMAC7.html) 1973-07-02

Similar Documents

Publication Publication Date Title
FI48975B (cg-RX-API-DMAC7.html)
AU5917865A (cg-RX-API-DMAC7.html)
AU424443B2 (cg-RX-API-DMAC7.html)
AU428063B2 (cg-RX-API-DMAC7.html)
AU417216B2 (cg-RX-API-DMAC7.html)
AU421822B2 (cg-RX-API-DMAC7.html)
AU414526B2 (cg-RX-API-DMAC7.html)
AU433222B2 (cg-RX-API-DMAC7.html)
AU5895065A (cg-RX-API-DMAC7.html)
AU612166A (cg-RX-API-DMAC7.html)
BE694557A (cg-RX-API-DMAC7.html)
BE694168A (cg-RX-API-DMAC7.html)
AU433620A (cg-RX-API-DMAC7.html)
BE654686A (cg-RX-API-DMAC7.html)
BE637138A (cg-RX-API-DMAC7.html)
AU414093B2 (cg-RX-API-DMAC7.html)
BE626310A (cg-RX-API-DMAC7.html)
BE624223A (cg-RX-API-DMAC7.html)
BE618801A (cg-RX-API-DMAC7.html)
BE597652A (cg-RX-API-DMAC7.html)
BE674987A (cg-RX-API-DMAC7.html)
BE662818A (cg-RX-API-DMAC7.html)
BE529218A (cg-RX-API-DMAC7.html)
BE666282A (cg-RX-API-DMAC7.html)
BE475118A (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: F. HOFFMANN-LA ROCHE & CIE S.A.

Effective date: 19870508